Related Experiment Video
Updated: Mar 21, 2026
11:15
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
5.6K
Learning from PD-1 Resistance: New Combination Strategies
Xia Bu1, Kathleen M Mahoney2, Gordon J Freeman1
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Trends in Molecular Medicine
|May 14, 2016
Summary
A minority of cancer patients benefit from anti programmed cell death protein 1 (PD-1) immunotherapy. Resistant melanoma patients show gene signatures linked to immunosuppression and tumor growth, suggesting combination therapies could improve treatment effectiveness.
Area of Science:
- Oncology
- Immunotherapy
- Cancer Genomics
Background:
- Anti-PD-1 immunotherapy is a key cancer treatment, but response rates remain limited.
- Understanding resistance mechanisms is crucial for improving patient outcomes.
Purpose of the Study:
- To identify molecular signatures associated with resistance to anti-PD-1 therapy in melanoma.
- To explore potential combination strategies to overcome treatment resistance.
Main Methods:
- Analysis of gene expression profiles in PD-1 therapy-resistant melanoma patients.
- Identification of upregulated gene pathways involved in key biological processes.
Main Results:
- Distinct gene signatures were observed in resistant melanoma, including pathways for immunosuppression, angiogenesis, and epithelial-mesenchymal transition (EMT).
- Upregulated genes related to monocyte/macrophase chemotaxis and extracellular matrix remodeling were also identified.
Conclusions:
- Melanoma patients resistant to PD-1 therapy exhibit specific molecular alterations.
- Targeting identified pathways (immunosuppression, angiogenesis, EMT, chemotaxis, matrix remodeling) in combination with PD-1 therapy may enhance antitumor immunity and overcome resistance.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:50Combination Therapies and Personalized Medicine
1.8K
1.8K
01:28Drug Therapy
387
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
387
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
70
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
70
01:27Combined Effects of Drugs: Synergism
7.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.2K